BetterLife Pharma (BETRF) Short Interest Ratio & Short Volume → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Free BETRF Stock Alerts $0.09 -0.01 (-10.31%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest BetterLife Pharma Short Interest DataCurrent Short Volume2,400 sharesPrevious Short Volume14,800 sharesChange Vs. Previous Month-83.78%Dollar Volume Sold Short$198.96Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares113,820,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume2,500 sharesAverage Trading Volume29,374 sharesToday's Volume Vs. Average9% Short Selling BetterLife Pharma ? Sign up to receive the latest short interest report for BetterLife Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBETRF Short Interest Over TimeBETRF Days to Cover Over TimeBETRF Percentage of Float Shorted Over Time Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… BetterLife Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,400 shares $198.96 -83.8%N/A0.1 $0.08 4/15/202414,800 shares $1,095.20 +516.7%N/A0.3 $0.07 3/31/20242,400 shares $168.00 No ChangeN/A0.1 $0.07 3/15/20242,400 shares $173.28 No ChangeN/A0 $0.07 2/29/20242,400 shares $148.80 -92.8%N/A0.1 $0.06 2/15/202433,200 shares $2,075.00 +0.3%N/A0.3 $0.06 Get the Latest News and Ratings for BETRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,900 shares $1,072.80 +520.8%N/A0.1 $0.07 12/31/20232,400 shares $115.10 -67.1%N/A0 $0.05 12/15/20237,300 shares $334.34 +204.2%N/A0.4 $0.05 11/30/20232,400 shares $109.92 No ChangeN/A0.1 $0.05 11/15/20232,400 shares $106.80 No ChangeN/A0.3 $0.04 10/31/20232,400 shares $110.35 No ChangeN/A0 $0.05 10/15/20232,400 shares $119.52 -7.7%N/A0 $0.05 9/30/20232,600 shares $134.58 +8.3%N/A0.1 $0.05 9/15/20232,400 shares $141.84 No ChangeN/A0.1 $0.06 8/31/20232,400 shares $155.52 No ChangeN/A0 $0.06 8/15/20232,400 shares $121.44 No ChangeN/A0 $0.05 7/31/20232,400 shares $125.76 -55.6%N/A0.1 $0.05 7/15/20235,400 shares $297.00 -81.6%N/A0.1 $0.06 6/30/202329,300 shares $1,611.50 +21.6%N/A0.6 $0.06 6/15/202324,100 shares $1,337.55 -49.2%N/A0.5 $0.06 5/31/202347,400 shares $2,820.30 No ChangeN/A1.4 $0.06 5/15/202347,400 shares $2,554.86 No ChangeN/A2 $0.05 4/30/202347,400 shares $2,938.80 No ChangeN/A4.1 $0.06 4/15/202347,400 shares $2,802.29 +867.4%N/A0.3 $0.06 3/31/20234,900 shares $298.90 -90.1%N/A0.1 $0.06 3/15/202349,300 shares $3,278.45 -43.5%N/A0.5 $0.07 2/28/202387,300 shares $7,804.62 No ChangeN/A1 $0.09 2/15/202387,300 shares $8,345.88 -32.9%N/A3.8 $0.10 1/31/2023130,100 shares $14,454.11 +4,718.5%N/A1.5 $0.11 1/15/20232,700 shares $337.50 No ChangeN/A0.2 $0.13 12/30/20222,700 shares $328.32 No ChangeN/A0 $0.12 12/15/20222,700 shares $351.00 -3.6%N/A0 $0.13 11/30/20222,800 shares $331.80 -91.6%N/A0.2 $0.12 11/15/202233,300 shares $4,085.91 +23.8%N/A0.6 $0.12 10/31/202226,900 shares $3,362.50 -24.7%N/A0.4 $0.13 10/15/202235,700 shares $4,873.05 -38.1%N/A1.2 $0.14 9/30/202257,700 shares $8,193.40 +12.0%N/A1.1 $0.14 9/15/202251,500 shares $7,915.55 -5.5%N/A0.8 $0.15 8/31/202254,500 shares $7,630.00 -3.9%N/A0.7 $0.14get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. BETRF Short Interest - Frequently Asked Questions What is BetterLife Pharma's current short interest? Short interest is the volume of BetterLife Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,400 shares of BETRF short. Learn More on BetterLife Pharma's current short interest. Is BetterLife Pharma's short interest increasing or decreasing? BetterLife Pharma saw a drop in short interest in April. As of April 30th, there was short interest totaling 2,400 shares, a drop of 83.8% from the previous total of 14,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BetterLife Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BetterLife Pharma: NuCana plc (1.21%), Addex Therapeutics Ltd (1.85%), Alterity Therapeutics Limited (1.03%), Molecular Templates, Inc. (4.68%), Chemomab Therapeutics Ltd. (0.98%), Aeterna Zentaris Inc. (0.34%), Galera Therapeutics, Inc. (7.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short BetterLife Pharma stock? Short selling BETRF is an investing strategy that aims to generate trading profit from BetterLife Pharma as its price is falling. BETRF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BetterLife Pharma? A short squeeze for BetterLife Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BETRF, which in turn drives the price of the stock up even further. How often is BetterLife Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BETRF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NCNA Short Squeeze ADXN Short Squeeze ATHE Short Squeeze MTEM Short Squeeze CMMB Short Squeeze AEZS Short Squeeze GRTX Short Squeeze GHSI Short Squeeze MBRX Short Squeeze OASMY Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BETRF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceHow Biden has already won 2024Porter & Company